The current study seeks to further define MMP-2 and MMP-9 protein levels and enzyme activity in the serum and CSF of ALS and compare their levels to those in the serum of age-matched, healthy controls (HCs) and CSF of other neurological diseases (OND). Here, MMP9 is linked to amyotrophic lateral sclerosis.